Pharma Focus America

Home
India
Hyderabad
Pharma Focus America

Welcome to Pharma focus America! We bring you the latest insights, innovations, and news from the world of pharmaceuticals. Ltd..

Join our community to stay updated and engage with industry experts! https://www.linkedin.com/company/pharmafocusamerica/ About Pharma Focus America:
Pharma Focus Aerica is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus America covers important issues and trends shaping the future of the pharma industry across America and rest of the world. Pharma Focus America offers . . .
• Dedicated, reliable and accurate coverage of the industry’s progress and
• Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:
• Strategy
• Research and Development
• Manufacturing
• Clinical Trials
• Information Technology

The one-stop pharma destination www.pharmafocusamerica.com features complete content from the Pharma Focus America magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership
The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on America, Pharma Focus America reaches out to the key industry leaders across America, Europe and the Asia.

30/09/2025

In life sciences, trustworthy data saves lives. 𝐂𝐚𝐭𝐡𝐞𝐫𝐢𝐧𝐞 𝐇𝐚𝐥𝐥, 𝐇𝐞𝐚𝐝 𝐨𝐟 𝐆𝐱𝐏 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐀𝐬𝐬𝐮𝐫𝐚𝐧𝐜𝐞 𝐚𝐭 𝐄𝐠𝐧𝐲𝐭𝐞, shares why strong data governance is critical—from research labs to patient care. With evolving regulations like ICH E6(R3), managing your data’s quality, security, and compliance is key to delivering safe, effective treatments faster.

Join the conversation on how your organization can overcome data challenges and build a culture that values data integrity every step of the way.

𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐲𝐨𝐮𝐫 𝐝𝐚𝐭𝐚 𝐠𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞? 𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞: https://www.pharmafocusamerica.com/information-technology/data-governance-in-life-sciences

29/09/2025

𝐇𝐨𝐰 𝐢𝐬 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐭𝐡𝐞 𝐰𝐚𝐲 𝐰𝐞 𝐤𝐞𝐞𝐩 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐬𝐚𝐟𝐞?

Pharmacovigilance experts Tanvi Chopra, Dr. William K. Sietsema, Dr. Kristen K. Buck, and Dr. Rajiv Maini share how AI is helping healthcare professionals detect and manage drug safety risks faster and more accurately than ever before. By automating routine tasks and analyzing vast amounts of data—from social media to medical records—AI supports human experts in protecting patient health worldwide.

While challenges like data privacy and regulatory hurdles exist, the future is bright with AI-human collaboration leading the way.

💡 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐡𝐨𝐰 𝐀𝐈 𝐜𝐚𝐧 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐲𝐨𝐮𝐫 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 𝐞𝐟𝐟𝐨𝐫𝐭𝐬? 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬!
https://www.pharmafocusamerica.com/information-technology/artificial-intelligence-meets-pharmacovigilance

29/09/2025

𝐓𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭-𝐜𝐞𝐧𝐭𝐞𝐫𝐞𝐝! Patients want to be heard, understood, and empowered—not just treated. By focusing on clear communication, education, and support, pharmaceutical companies can build real relationships that improve health outcomes and trust.

Let’s work together to create a healthcare environment where patients feel like partners, not just consumers. Join the conversation and learn how patient-centric pharma is changing lives for the better.

𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐧𝐝 𝐠𝐞𝐭 𝐢𝐧𝐯𝐨𝐥𝐯𝐞𝐝:
https://www.pharmafocusamerica.com/articles/patient-centric-pharma-how-to-engage-educate-and-empower

26/09/2025

𝐏𝐡𝐚𝐫𝐦𝐚 𝐬𝐮𝐩𝐩𝐥𝐲 𝐜𝐡𝐚𝐢𝐧𝐬 𝐚𝐫𝐞 𝐟𝐚𝐜𝐢𝐧𝐠 𝐧𝐞𝐰 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐰𝐢𝐭𝐡 𝐫𝐢𝐬𝐢𝐧𝐠 𝐭𝐚𝐫𝐢𝐟𝐟𝐬—𝐛𝐮𝐭 𝐚𝐥𝐬𝐨 𝐧𝐞𝐰 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬!

𝐌𝐚𝐫𝐢𝐚 𝐌𝐚𝐥𝐢𝐧 𝐚𝐧𝐝 𝐉𝐚𝐬𝐨𝐧 𝐋𝐞𝐧𝐨𝐫𝐞 𝐟𝐫𝐨𝐦 𝐀𝐛𝐳𝐞𝐧𝐚 share expert insights on how drug developers can navigate these changes by building stronger, more resilient supply chains focused on U.S.-based partnerships and smarter risk management. This means better continuity, compliance, and ultimately, faster patient access to life-saving therapies.

Join the conversation and learn how innovation and collaboration are key to overcoming today’s trade hurdles.

👉 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐡𝐞𝐫𝐞:
https://www.pharmafocusamerica.com/manufacturing/navigating-the-tariff-landscape

25/09/2025

The future of pharmacy compounding is here! 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝟑𝐃 𝐩𝐫𝐢𝐧𝐭𝐢𝐧𝐠 is transforming how we create personalized medicine, making it faster, safer, and more cost-effective.

Imagine reducing preparation time by 10% and costs by 35% while improving quality control—all while creating medicines tailored to individual patient needs, like chewable tablets for kids or multi-drug 𝐩𝐨𝐥𝐲𝐩𝐢𝐥𝐥𝐬.

This isn't science fiction. Hospitals like Gustave Roussy in Europe and St. Jude in the US are already leading the charge. How could this technology benefit your practice or patients?

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐭𝐨 𝐠𝐞𝐭 𝐬𝐭𝐚𝐫𝐭𝐞𝐝? 𝐂𝐥𝐢𝐜𝐤 𝐭𝐨 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐞𝐚𝐬𝐲 𝐠𝐮𝐢𝐝𝐞 𝐭𝐨 𝐢𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐢𝐧𝐠 𝟑𝐃 𝐩𝐫𝐢𝐧𝐭𝐢𝐧𝐠 𝐢𝐧 𝐲𝐨𝐮𝐫 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐲!
https://www.pharmafocusamerica.com/manufacturing/pharmaceutical-3d-printing-bringing-compounding

24/09/2025

The convergence of AI and pharmaceutical science is no longer a future concept—it's accelerating drug discovery, optimizing clinical trials, and personalizing patient therapies today. For leaders shaping the future of medicine, understanding this shift is imperative.

Join us at the 𝐀𝐈 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 & 𝐏𝐡𝐚𝐫𝐦𝐚 𝐒𝐮𝐦𝐦𝐢𝐭 (𝐍𝐨𝐯 𝟏𝟖-𝟏𝟗, 𝐁𝐨𝐬𝐭𝐨𝐧) to engage with 30+ experts on the strategic implementation of AI. We'll delve into critical topics like navigating regulatory landscapes, ensuring responsible AI, and translating data into tangible patient outcomes.

This is your final chance to secure the lowest price. The Early Bird discount ends this Friday, September 27. Use code 𝐒𝐀𝐕𝐄𝟑𝟎 at checkout for an additional 30% off.

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐥𝐞𝐚𝐝 𝐭𝐡𝐞 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧:
https://industry.pharmafocusamerica.com/clientemailblast/1758602870-AI-in-Healthcare-&-Pharma-Summit.html

24/09/2025

The paradigm of clinical research is shifting. The integration of 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 (𝐑𝐖𝐄), patient registries, and 𝐃𝐞𝐜𝐞𝐧𝐭𝐫𝐚𝐥𝐢𝐳𝐞𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 (𝐃𝐂𝐓𝐬) is no longer a niche approach but a strategic imperative for next-generation innovation.

As 𝐒𝐨𝐰𝐦𝐲𝐚 𝐊𝐚𝐮𝐫, 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐕𝐢𝐜𝐞 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐚𝐭 𝐍𝐚𝐯𝐢𝐭𝐚𝐬 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬, outlines, this synergy is bridging the gap between traditional RCTs and real-world practice, accelerating drug development and enhancing patient-centricity. Regulatory bodies like the FDA and EMA are increasingly accepting RWE for new indications, making a robust data ecosystem critical for market access.

𝐊𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:
➡️ RWE from EHRs and registries is optimizing hybrid trial designs.
➡️ Patient registries provide a rich, longitudinal data source for recruitment and outcomes.
➡️ DCTs expand access and improve retention through digital tools.

The future belongs to those who can seamlessly integrate these elements for smarter, faster, and more inclusive research.

𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐥𝐞𝐯𝐞𝐫𝐚𝐠𝐞 𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞𝐝 𝐑𝐖𝐄 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐬𝐭𝐫𝐲 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐲𝐨𝐮𝐫 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐬? 𝐆𝐚𝐢𝐧 𝐝𝐞𝐞𝐩𝐞𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞.
https://www.pharmafocusamerica.com/clinical-trials/leveraging-real-world-evidence-registries-and-decentralized

23/09/2025

The landscape of oncology drug approval is evolving rapidly, and 𝐒𝐢𝐧𝐠𝐥𝐞-𝐀𝐫𝐦 𝐓𝐫𝐢𝐚𝐥𝐬 (𝐒𝐀𝐓𝐬) are at the forefront. A compelling analysis reveals that nearly 90% of European Medicines Agency (EMA) oncology approvals based on SATs have been successful.

This pragmatic approach is crucial as we approach the pivotal 2025 deadline for joint 𝐄𝐌𝐀 𝐚𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 (𝐇𝐓𝐀) evaluations. The article delves into the key design features that drive SAT success—from precise patient selection and robust endpoint selection to the strategic use of contextual evidence.

Furthermore, it explores the nuanced differences between the EMA and FDA in their acceptance of SATs, a critical consideration for global development strategies.

𝐊𝐞𝐲 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲 𝐟𝐨𝐫 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐥𝐞𝐚𝐝𝐞𝐫𝐬: Success in this new era requires an integrated evidence generation strategy that satisfies both regulatory and HTA value demands from the outset. Proactive engagement and cross-functional collaboration are no longer optional but essential.

𝐖𝐞 𝐭𝐡𝐚𝐧𝐤 𝐚𝐮𝐭𝐡𝐨𝐫𝐬 𝐕𝐢𝐤𝐫𝐚𝐦 𝐆𝐨𝐬𝐚𝐢𝐧 𝐚𝐧𝐝 𝐀𝐧𝐝𝐫𝐢𝐬 𝐎𝐫𝐭𝐦𝐚𝐧𝐢𝐬, 𝐒𝐞𝐧𝐢𝐨𝐫 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫 𝐚𝐭 𝐈𝐧𝐢𝐳𝐢𝐨, 𝐟𝐨𝐫 𝐭𝐡𝐞𝐢𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬.

What is your organization doing to prepare for the integrated regulatory and HTA landscape?

➡️ Gain a deeper understanding of the strategic implications. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐢𝐧 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐡𝐞𝐫𝐞:
https://www.pharmafocusamerica.com/clinical-trials/why-single-arm-trials-are-gaining-ground-in-oncology-approvals

22/09/2025

𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐭𝐞𝐚𝐦𝐬: 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐬𝐭𝐫𝐮𝐠𝐠𝐥𝐢𝐧𝐠 𝐭𝐨 𝐬𝐞𝐞 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐩𝐢𝐜𝐭𝐮𝐫𝐞 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐬𝐭𝐮𝐝𝐲'𝐬 𝐫𝐞𝐜𝐫𝐮𝐢𝐭𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐫𝐞𝐭𝐞𝐧𝐭𝐢𝐨𝐧?

Our new article from Magazine Issue 06, featuring experts from WCG, breaks down how a centralized technology platform can be a game-changer. It’s all about working smarter, not harder, to keep trials on track and ensure patients get the support they need.

𝐖𝐞 𝐝𝐢𝐬𝐜𝐮𝐬𝐬:
✨ How to get all your sites on the same page (literally!)
✨ Spotting problems before they derail your timeline
✨ Freeing up your staff from tedious paperwork
✨ Using tech to improve the participant experience globally

What's your biggest challenge with trial recruitment? Share in the comments!

𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐡𝐞𝐫𝐞:
https://www.pharmafocusamerica.com/clinical-trials/enabling-successful-trial-recruitment-through-centralized

22/09/2025

The pharmaceutical industry stands at a pivotal crossroads: delivering life-saving therapies while confronting its significant environmental footprint. The solution? A strategic pivot to Green Chemistry.

This isn't just an ethical imperative; it's a business and innovation catalyst. By integrating sustainable drug manufacturing principles—like 𝐛𝐢𝐨𝐜𝐚𝐭𝐚𝐥𝐲𝐬𝐢𝐬, 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐠𝐫𝐞𝐞𝐧 𝐬𝐨𝐥𝐯𝐞𝐧𝐭𝐬—we can drastically reduce waste, lower costs, and enhance process safety.

The future of pharma is not just about what we make, but how we make it. Leading companies like Pfizer and Novartis are already demonstrating that sustainability and profitability are not mutually exclusive. We explore how green chemistry is reshaping drug development for a carbon-neutral future.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐧 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐩𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 𝐡𝐞𝐫𝐞:
https://www.pharmafocusamerica.com/articles/green-chemistry-in-pharma-sustainable-drug-manufacturing

19/09/2025

𝐀𝐫𝐞 𝐲𝐨𝐮𝐫 𝐬𝐢𝐥𝐨𝐞𝐝 𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐚𝐧𝐝 𝐩𝐚𝐩𝐞𝐫-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬 𝐜𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐮𝐧𝐬𝐞𝐞𝐧 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐫𝐢𝐬𝐤𝐬? For fast-growing life sciences companies, this isn't just an operational hurdle—it's a strategic vulnerability.

With only 39% of companies treating quality as a strategic initiative, the gap between growth and governance is widening. The solution lies in integrated, digital transformation.
𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐡𝐨𝐰 𝐇𝐮𝐯𝐞𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝 𝐞𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞-𝐰𝐢𝐝𝐞 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐞𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞:
✅ Standardized processes across 90+ global sites with minimal customization.
✅ Successfully migrated critical documents from paper to digital in 4 countries.
✅ Enhanced their customer complaints process while accelerating compliance.

Learn how to turn your quality management system into a competitive advantage.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝐭𝐨 𝐬𝐜𝐚𝐥𝐞 𝐲𝐨𝐮𝐫 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐭𝐥𝐲
https://industry.pharmafocusamerica.com/clientemailblast/1758086905-ETQ,-part-of-Hexagon---Are-Siloed-Systems.html

19/09/2025

How do we prove a new drug works for rare diseases when patient numbers are small and data is highly variable? The old rules might not be the best way!

A fantastic new article by 𝐃𝐫. 𝐒𝐡𝐞𝐢𝐧-𝐂𝐡𝐮𝐧𝐠 𝐂𝐡𝐨𝐰 breaks down a controversial issue in drug development. He suggests a new approach using confidence intervals and precision analysis could be more effective and reliable than the traditional p-value method.

This is a big deal for researchers, clinicians, and advocates in the rare disease community. It’s about fostering innovation to get critical treatments to patients faster.

What are your thoughts on modernizing clinical trial standards?

👉 𝐂𝐥𝐢𝐜𝐤 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐭𝐨 𝐫𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐢𝐧 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐦𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐚𝐧𝐝 𝐣𝐨𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧!
https://www.pharmafocusamerica.com/research-development/a-controversial-issue-in-clinical-investigation

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞: https://www.pharmafocusamerica.com/magazine

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

https://www.pharmafocusamerica.com/

Alerts

Be the first to know and let us send you an email when Pharma Focus America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Hyderabad?

30/09/2025

29/09/2025

29/09/2025

26/09/2025

25/09/2025

24/09/2025

24/09/2025

23/09/2025

22/09/2025

22/09/2025

19/09/2025

19/09/2025

Address

Website

Alerts

Shortcuts

Share

Category